stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Return on invested capital
AtriCure, Inc.'s return on invested capital over the twelve months to 30 September 2026 was 2.61%, up 4.1 percentage points from fiscal 2025 (−1.53%). Over the past ten years it has ranged from −11.9% (fiscal 2016) to 7.91% (fiscal 2021); the current reading is higher than 91% of that period. That is above the Medical Instruments & Supplies industry median of 0.13% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −1.53% | 4.72 |
| FY2024 | −6.25% | (1.97) |
| FY2023 | −4.28% | 2.27 |
| FY2022 | −6.55% | (14.46) |
| FY2021 | 7.91% | 19.71 |
| FY2020 | −11.8% | (3.14) |
| FY2019 | −8.66% | (2.63) |
| FY2018 | −6.03% | 3.48 |
| FY2017 | −9.51% | 2.41 |
| FY2016 | −11.9% | (1.85) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| NVST Envista Holdings Corporation compare | 13.6% |
| MMSI Merit Medical Systems, Inc. compare | 6.87% |
| STVN Stevanato Group S.p.A. compare | 6.71% |
| ATRC AtriCure, Inc. | 2.61% |
| ICUI ICU Medical, Inc. compare | 2.27% |
| WRBY Warby Parker Inc. compare | 0.83% |
| XRAY DENTSPLY SIRONA Inc. compare | −1.09% |
| MMED MiniMed Group, Inc. compare | −1.61% |
| PLSE Pulse Biosciences, Inc compare | −37.0% |
| Medical Instruments & Supplies industry median | 0.13% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement